• Topics

  • Formats

Organiser: Improvado

Author(s): Roman Vinogradov

Pharma marketing strategy in 2026 requires parallel execution across direct-to-consumer (DTC) and healthcare professional (HCP) channels with unified measurement, automated compliance governance, and real-time data orchestration.

This blueprint integrates patient acquisition campaigns with provider engagement programs through governed infrastructure that handles PHI/PII, enables cross-channel attribution, and maintains FDA 21 CFR 202.1 and EU AI Act compliance across both tracks.

Reading this content is completely free

Enjoy Unlimited Access and Unlock
Additional Features with a Free Account

Join Now

You are attempting to log out of MyMA

Do you really want to log out?